Yu-Min Lin Selected Research

Induced Heart Arrest (Cardioplegia)

4/2013	Carvedilol treatment after myocardial infarct decreases cardiomyocytic apoptosis in the peri-infarct zone during cardioplegia-induced cardiac arrest.
12/2012	MicroRNA-27a regulates cardiomyocytic apoptosis during cardioplegia-induced cardiac arrest by targeting interleukin 10-related pathways.
9/2010	Cardiomyocytic apoptosis limited by bradykinin via restoration of nitric oxide after cardioplegic arrest.
1/2010	AMP-activated protein kinase activation during cardioplegia-induced hypoxia/reoxygenation injury attenuates cardiomyocytic apoptosis via reduction of endoplasmic reticulum stress.
7/2009	HO-1 activation can attenuate cardiomyocytic apoptosis via inhibition of NF-kappaB and AP-1 translocation following cardiac global ischemia and reperfusion.
9/2006	Cardiomyocytic apoptosis following global cardiac ischemia and reperfusion can be attenuated by peroxisome proliferator-activated receptor alpha but not gamma activators.
2/2006	Inhibition of poly(adp-ribose) polymerase reduces cardiomyocytic apoptosis after global cardiac arrest under cardiopulmonary bypass.
5/2005	Inhibition of NFkappaB activation with curcumin attenuates plasma inflammatory cytokines surge and cardiomyocytic apoptosis following cardiac ischemia/reperfusion.
4/2005	Inhibition of NF-kappa B activation can attenuate ischemia/reperfusion-induced contractility impairment via decreasing cardiomyocytic proinflammatory gene up-regulation and matrix metalloproteinase expression.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yu-Min Lin Research Topics

Disease

15	Neoplasms (Cancer) 01/2018 - 10/2003
8	Colorectal Neoplasms (Colorectal Cancer) 01/2021 - 06/2002
8	Ischemia 09/2010 - 08/2004
7	Reperfusion Injury 12/2012 - 08/2004
6	Infections 01/2019 - 04/2002
6	Neoplasm Metastasis (Metastasis) 01/2016 - 02/2004
6	Heart Arrest (Cardiac Arrest) 12/2012 - 08/2004
5	Carcinogenesis 01/2018 - 10/2003
5	Myocardial Ischemia (Ischemic Heart Diseases) 07/2009 - 04/2005
4	Hepatocellular Carcinoma (Hepatoma) 01/2021 - 11/2013
4	Hypoxia (Hypoxemia) 01/2015 - 01/2010
3	Leukemia 01/2018 - 07/2015
3	Osteosarcoma (Osteogenic Sarcoma) 01/2016 - 01/2013
3	Inflammation (Inflammations) 04/2013 - 07/2009
3	Wounds and Injuries (Trauma) 09/2006 - 04/2002
3	Crush Syndrome 07/2003 - 04/2002
2	Osteoarthritis 09/2020 - 01/2012
2	Obesity 12/2019 - 01/2010
2	Acute Promyelocytic Leukemia 01/2018 - 01/2018
2	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2018 - 09/2011
2	Rheumatoid Arthritis 01/2017 - 06/2003
2	Experimental Arthritis 01/2017 - 05/2016
2	Carcinoma (Carcinomatosis) 10/2016 - 02/2004
2	Alzheimer Disease (Alzheimer's Disease) 07/2015 - 04/2015
2	Chronic Hepatitis C 10/2014 - 11/2011
2	Prostatic Neoplasms (Prostate Cancer) 01/2014 - 08/2011
2	Cardiovascular Diseases (Cardiovascular Disease) 12/2012 - 12/2007
2	Glioma (Gliomas) 05/2009 - 09/2008
2	Colonic Neoplasms (Colon Cancer) 02/2004 - 10/2003
2	Adenoma (Adenomas) 02/2004 - 06/2002
1	Dementia (Dementias) 01/2021
1	Cognitive Dysfunction 01/2021
1	Rectal Neoplasms (Rectal Cancer) 01/2021
1	Insulin Resistance 01/2019
1	Hepatitis C 01/2019
1	Hepatitis 01/2019
1	Anxiety Disorders (Anxiety Disorder) 01/2019
1	Hip Fractures (Intertrochanteric Fractures) 08/2018
1	Liver Neoplasms (Liver Cancer) 01/2018
1	Triple Negative Breast Neoplasms 01/2018
1	Hypertension (High Blood Pressure) 10/2016

Drug/Important Bio-Agent (IBA)

8	Proteins (Proteins, Gene)FDA Link 01/2019 - 08/2004
7	CytokinesIBA 05/2016 - 05/2005
6	Complementary DNA (cDNA)IBA 12/2004 - 06/2002
5	NF-kappa B (NF-kB)IBA 09/2010 - 04/2005
4	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 01/2018 - 09/2006
3	LipidsIBA 01/2019 - 10/2014
3	MicroRNAs (MicroRNA)IBA 01/2018 - 07/2012
3	Small Interfering RNA (siRNA)IBA 01/2017 - 01/2013
3	Biomarkers (Surrogate Marker)IBA 10/2016 - 09/2011
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2016 - 01/2014
3	Transcription Factor AP-1 (Transcription Factor AP 1)IBA 01/2014 - 07/2009
3	Crystalloid SolutionsIBA 12/2012 - 05/2005
3	Calcibiotic Root Canal SealerIBA 11/2004 - 02/2004
2	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 09/2020 - 01/2013
2	LigandsIBA 01/2019 - 01/2012
2	Matrix Metalloproteinases (MMPs)IBA 01/2019 - 04/2005
2	Glucose (Dextrose)FDA LinkGeneric 01/2019 - 08/2009
2	Messenger RNA (mRNA)IBA 01/2018 - 12/2012
2	Pharmaceutical PreparationsIBA 01/2018 - 12/2004
2	Tretinoin (Retinoic Acid)FDA LinkGeneric 01/2018 - 01/2018
2	Oncogene Proteins (Oncogene Protein)IBA 01/2018 - 11/2004
2	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2018 - 08/2004
2	Interferon-alpha (Interferon Alfa)IBA 10/2016 - 10/2014
2	Fluoxetine (Prozac)FDA LinkGeneric 10/2016 - 10/2014
2	erucylphosphocholineIBA 05/2016 - 01/2016
2	ChemokinesIBA 01/2015 - 01/2012
2	Reactive Oxygen Species (Oxygen Radicals)IBA 10/2014 - 09/2006
2	BradykininIBA 01/2014 - 09/2010
2	Phosphates (Orthophosphate)IBA 04/2013 - 12/2012
2	Saline SolutionIBA 04/2013 - 12/2012
2	SolutionsIBA 12/2012 - 01/2010
2	Death-Associated Protein KinasesIBA 07/2012 - 09/2007
2	Peptides (Polypeptides)IBA 04/2010 - 12/2007
2	Nitric Oxide DonorsIBA 09/2008 - 08/2004
2	CaspasesIBA 09/2006 - 02/2006
2	potassium cardioplegic solutionIBA 02/2006 - 08/2004
1	Axitinib (AG 013736)IBA 01/2021
1	Vascular Endothelial Growth Factor Receptor-1 (fms-Like Tyrosine Kinase)IBA 01/2021
1	Nicotinamide PhosphoribosyltransferaseIBA 09/2020
1	TrypsinIBA 12/2019
1	etifoxineIBA 01/2019
1	Arsenic Trioxide (Trisenox)FDA Link 01/2018
1	Trypan Blue FDA Link 01/2018
1	Calcitriol Receptors (Calcitriol Receptor)IBA 01/2018
1	NIMA-Interacting Peptidylprolyl IsomeraseIBA 01/2018
1	IsomerasesIBA 01/2018
1	Calcitriol (Calcijex)FDA LinkGeneric 01/2018
1	Tetracycline (Achromycin)FDA LinkGeneric 01/2018
1	ArsenicIBA 01/2018
1	procollagen Type III-N-terminal peptide (PIIP)IBA 10/2016
1	Matrix Metalloproteinase 2 (Gelatinase A)IBA 10/2016

Therapy/Procedure

9	Therapeutics 01/2018 - 06/2003
9	Induced Heart Arrest (Cardioplegia) 04/2013 - 04/2005
6	Cardiopulmonary Bypass (Heart-Lung Bypass) 07/2009 - 08/2004
3	Fasciotomy 07/2003 - 04/2002
2	Immunotherapy 01/2021 - 08/2004
1	Radiotherapy 01/2021
1	Neoadjuvant Therapy 01/2021
1	X-Ray Film 08/2018